文献速递传染病防控与疫情报告免疫规划

从首次感染到再感染:比较接种与未接种成人中的核衣壳抗体动力学

From first infection to reinfection: Comparing Nucleocapsid antibody kinetics in vaccinated and unvaccinated adults.
PubMed 文献 · Vaccine · 2025-08-13

该研究测量接种与未接种成人首次和第二次SARS-CoV-2感染前后的核衣壳抗体,用加速失效时间模型评估抗体衰减。首次感染后未接种者95.8%(88.5-98.6%)与接种者89.4%(86.5-91.7%)血清阳转;接种者血清阳性持续时间缩短45.5%(事件时间比=0.55,95%CI:0.45-0.66)。第二次感染后接种者89.1%(76.9-95.3%)与未接种者94.4%(74.2-99.0%)抗体水平4倍升高,且无论接种状态,第二次感染后抗体水平显著高于首次感染后。

要点

  • 首次感染后未接种者95.8%与接种者89.4%核衣壳抗体血清阳转。
  • 接种成人血清阳性持续时间较未接种成人缩短45.5%(事件时间比=0.55)。
  • 第二次感染后接种者89.1%与未接种者94.4%出现抗体4倍升高。

核心结论

  • 核衣壳血清学可提示既往感染,无论暴露状态如何,并可能区分初次感染与再感染。

研究设计与样本

  • 研究测量接种与未接种成人首次和第二次SARS-CoV-2感染前后的核衣壳抗体存在与水平,并用加速失效时间模型评估抗体衰减。

主要发现

  • 首次感染后未接种者95.8%(88.5-98.6%)与接种者89.4%(86.5-91.7%)血清阳转。
  • 接种成人血清阳性持续时间较未接种成人缩短45.5%(事件时间比=0.55,95%CI:0.45-0.66)。
  • 第二次感染后接种者89.1%(76.9-95.3%)与未接种者94.4%(74.2-99.0%)抗体水平4倍升高。
  • 无论接种状态,第二次感染后抗体水平显著高于首次感染后。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Determining infection histories of individuals with prior immunity is critical to studying SARS-CoV-2 imprinting and vaccine responses. To better understand the response to infection, we examine nucleocapsid protein antibody dynamics around first and second SARS-CoV-2 infections in vaccinated and unvaccinated adults. METHODS: The presence and levels of nucleocapsid-antibodies were measured around first and second SARS-CoV-2 infections. Antibody waning was measured with accelerated failure time models. RESULTS: After first-infections 95.8 % (88.5-98.6 %) of unvaccinated and 89.4 % (86.5-91.7 %) of vaccinated participants seroconverted. Vaccinated adults had 45.5 % shorter seropositivity (event time ratio = 0.55, 95 %CI: 0.45-0.66). After second-infections, 89.1 % (76.9-95.3 %) of vaccinated and 94.4 % (74.2-99.0 %) of unvaccinated participants had a 4-fold rise in antibody levels. Regardless of vaccination, antibody levels after second-infections are significantly higher than after first-infections. CONCLUSIONS: These findings suggest nucleocapsid serology can inform researchers about past infections regardless of exposure status, and potentially differentiate between initial infections and reinfections.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Lindsey KM, Farrell Z, Tutino R, et al. From first infection to reinfection: Comparing Nucleocapsid antibody kinetics in vaccinated and unvaccinated adults. Vaccine. 2025. PMID: 40812020. doi:10.1016/j.vaccine.2025.127593

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。